# Annex 1: Revision 2020 and ISPE Commenting

#### Extended Learning Learning Level: Basic/Intermediate

Annex 1, the section of the EU GMPs that regulates the manufacturing of sterile products, has been valid in the current version since 2009. In 2017, EMA published a revised draft version for general comments. This was followed by another draft version in 2020, this time only for a targeted stakeholder consultation. As one of the stakeholders, ISPE has had the chance to provide input into Annex 1. This webinar will explain the process of the 2020 commenting, including the collaboration with other industry organizations like PDA, PHSS, EFPIA and many others. The webinar will also touch on the most relevant paragraphs that ISPE commented on.

## Learning Objectives

1. Understand the current status of commenting on Annex 1
2. Understand the most relevant topics in Annex 1 and ISPE’s position in the commenting
3. Consider the application of the revised Annex 1 on the operation of facilities for sterile products
Webinar Rates

ON DEMAND ACCESS FOR 90 DAYS

 Member $99 Nonmember$149 Student* \$25

*ISPE Membership is required for these rates.

## Speakers

Jean-Francois Duliere
Pharmaceutical Senior Expert, Consultant, Chair ISPE France Affiliate
Jörg Zimmermann
Vice President, Vetter Development Service, External Affairs
Vetter Pharma-Fertigung GmbH & Co.